Business
Sernova CEO to Present Regenerative Medicine Therapeutics Platform Update at the 2021 Cell & Gene Therapy Meeting on the Med
(TheNewswire) LONDON, ONTARIO – TheNewswire - Januar...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova CEO to Present Regenerative Medicine Therapeutics Platform Update at the 2021 Cell & Gene Therapy Meeting on the Med\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n LONDON, ONTARIO –\n \n TheNewswire -\n \n January 21,\n2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a\nclinical-stage regenerative medicine company announced today that Dr.\nPhilip Toleikis, President and CEO has been invited to participate at\nthe Cell & Gene Virtual Meeting on the Med, and available\non-demand to attendees beginning Thursday, April 6 to 9. Dr. Toleikis\nwill deliver a corporate update on Sernova’s regenerative medicine\ntherapeutics platform including our US clinical cell therapy diabetes\nprogram as part of the 2021 Company Presentations at the Cell &\nGene Meeting on the Med.\n \n \n Sernova’s Corporate Update presentation will be available on-demand\nto attendees of the Virtual Cell & Gene Meeting on the Med\nthroughout the conference. For more details on Sernova’s\npresentation, please visit\n \n \n www.meetingonthemed.com\n \n \n .\n \n \n \n ABOUT SERNOVA CORP.\n \n \n \n Sernova Corp is developing regenerative medicine therapeutic solutions\nusing a medical device (Cell Pouch™) and immune protected\ntherapeutic cells/tissues (i.e., human donor cells, corrected human\ncells and stem cell-derived cells) to improve the treatment and\nquality of life of people with chronic metabolic diseases such as\ninsulin-dependent diabetes, blood disorders including hemophilia, and\nother diseases treated through cellular production of proteins or\nhormones missing or in short supply within the body. For more\ninformation, please visit\n \n \n www.sernova.com\n \n \n .\n \n \n \n ABOUT SERNOVA’S CELL POUCH™\nSYSTEM\n \n \n \n The Cell Pouch™, as part of the Cell Pouch™ System, is a novel,\nproprietary, scalable, implantable macro- encapsulation device\nsolution designed for the long-term survival and function of\ntherapeutic cells. The device upon implantation is designed to\nincorporate with tissue, forming highly vascularized tissue chambers\nfor the transplantation and function of therapeutic cells, which then\nrelease proteins and hormones as required to treat disease. The Cell\nPouch™, along with therapeutic cells, ...